Altered p16INK4a and Fhit expression in carcinogenesis and progression of human oral cancer

被引:3
作者
Paradiso, A
Ranieri, G
Stea, B
Zito, A
Zehbe, I
Tommasino, M
Grammatica, L
De Lena, M
机构
[1] Natl Canc Inst, Clin Expt Oncol Lab, I-70126 Bari, Italy
[2] Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany
关键词
head and neck cancers; tumor suppressor gene expression; human papillomavirus;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To further characterize the biological and clinical role of molecular alterations involved in oral squamous carcinogenesis, the immunohistochemical expression level of two tumor suppressor genes, fragile histidine triad and p16(INK4a), in non-carcinomatous squamous epithelia and head and neck squamous cell carcinoma was determined. In addition, human papillomavirus infection determined by PCR assay and the use of alcohol and cigarettes were evaluated. In this study 28 non-carcinomatous squamous epithelia and 57 head and neck squamous cell carcinoma were considered. The expression levels of fragile histidine triad were lower in head and neck squamous cell carcinoma than in non-carcinomatous squamous epithelia. In contrast, p16(INK4a) is expressed in malignant lesions (51% of the cases analyzed), but not in non-carcinomatous squamous epithelia. No correlation between gene expression alterations of the two tumor suppressors was observed. PCR analysis showed that HPV DNA was present in 5 of the 57 malignant lesions analyzed (8.8%). None of the factors described above, despite changes in gene expression and HPV infection, appears to be associated with alcohol use and/or tobacco smoking and clinical outcome. Our data showed that fragile histidine triad and p16(INK4a) expression are altered in malignant lesions. Most likely, the decreasing levels of fragile histidine triad is directly involved in cancer development, while the accumulation of p16(INK4a) in head and neck squamous cell carcinoma may be the consequence of loss of functional tumor suppressor retinoblastoma pathway.
引用
收藏
页码:249 / 255
页数:7
相关论文
共 36 条
  • [1] BLOT WJ, 1988, CANCER RES, V48, P3282
  • [2] BRACHMAN DG, 1994, SEMIN ONCOL, V21, P320
  • [3] RATES OF P16(MTS1) MUTATIONS IN PRIMARY TUMORS WITH 9P LOSS
    CAIRNS, P
    MAO, L
    MERLO, A
    LEE, DJ
    SCHWAB, D
    EBY, Y
    TOKINO, K
    VANDERRIET, P
    BLAUGRUND, JE
    SIDRANSKY, D
    [J]. SCIENCE, 1994, 265 (5170) : 415 - 416
  • [4] FREQUENCY OF HOMOZYGOUS DELETION AT P16/CDKN2 IN PRIMARY HUMAN TUMORS
    CAIRNS, P
    POLASCIK, TJ
    EBY, Y
    TOKINO, K
    CALIFANO, J
    MERLO, A
    MAO, L
    HERATH, J
    JENKINS, R
    WESTRA, W
    RUTTER, JL
    BUCKLER, A
    GABRIELSON, E
    TOCKMAN, M
    CHO, KR
    HEDRICK, L
    BOVA, GS
    ISAACS, W
    KOCH, W
    SCHWAB, D
    SIDRANSKY, D
    [J]. NATURE GENETICS, 1995, 11 (02) : 210 - 212
  • [5] Human papillomavirus type 32 does not display in vitro transforming properties
    Caldeira, S
    Dong, W
    Tomakidi, P
    Paradiso, A
    Tommasino, M
    [J]. VIROLOGY, 2002, 301 (01) : 157 - 164
  • [6] Role of FHIT in human cancer
    Croce, CM
    Sozzi, G
    Huebner, K
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (05) : 1618 - 1624
  • [7] Dumon KR, 2001, CANCER RES, V61, P4827
  • [8] Grammatica L, 2001, J EXP CLIN CANC RES, V20, P225
  • [9] A CELL-CYCLE REGULATOR POTENTIALLY INVOLVED IN GENESIS OF MANY TUMOR TYPES
    KAMB, A
    GRUIS, NA
    WEAVERFELDHAUS, J
    LIU, QY
    HARSHMAN, K
    TAVTIGIAN, SV
    STOCKERT, E
    DAY, RS
    JOHNSON, BE
    SKOLNICK, MH
    [J]. SCIENCE, 1994, 264 (5157) : 436 - 440
  • [10] Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates:: implications for cervical disease
    Kämmer, C
    Tommasino, M
    Syrjänen, S
    Delius, H
    Hebling, U
    Warthorst, U
    Pfister, H
    Zehbe, I
    [J]. BRITISH JOURNAL OF CANCER, 2002, 86 (02) : 269 - 273